Fibrosclerosis of breast
ICD-10 N60.3 is a billable code used to indicate a diagnosis of fibrosclerosis of breast.
Fibrosclerosis of the breast is a benign condition characterized by the proliferation of fibrous tissue within the breast, often resulting in a firm, rubbery texture. This condition may be associated with other benign breast diseases, such as fibrocystic changes, and can present with symptoms like breast lumps or localized tenderness. Fibrosclerosis can occur in one or both breasts and is often discovered during routine breast imaging or physical examination. While it is not cancerous, it can sometimes mimic malignancy on imaging studies, necessitating further evaluation. The etiology of fibrosclerosis is not fully understood but may involve hormonal influences, particularly estrogen. Patients may report symptoms such as nipple discharge or breast pain, which can complicate the clinical picture. Diagnosis typically involves imaging studies such as mammography or ultrasound, followed by biopsy if necessary to rule out malignancy. Management is usually conservative, focusing on symptom relief and regular monitoring.
Detailed imaging reports including descriptions of findings and recommendations for follow-up.
Imaging for breast lumps, follow-up of previously identified fibrosclerosis.
Ensure clarity in distinguishing benign from malignant findings on imaging.
Operative reports detailing findings and any interventions performed.
Surgical excision of suspicious breast lumps, biopsy of fibrosclerotic tissue.
Document rationale for surgical intervention versus conservative management.
Used when surgical intervention is required for fibrosclerosis.
Operative report detailing the procedure and findings.
Ensure clear documentation of the indication for surgery.
The primary treatment for fibrosclerosis is usually conservative management, including monitoring and symptom relief. Surgical intervention may be considered if there are significant symptoms or concerns about malignancy.
